 |
Terrance H. Gregg
President & CEO, Dexcom, Inc.
|
Terrance H. Gregg is President and CEO of DexCom, Inc . He is also currently a Special Venture Partner with Galen Partners, a private equity firm specializing in the healthcare industry. In 2002 he retired as President of Medtronic MiniMed, a world leader in diabetes management systems. He became President and Chief Operating Officer of MiniMed, Inc. in 1996 and was instrumental in Medtronic's $3.4 billion acquisition of MiniMed in 2001. He also served in executive positions with Smith and Nephew and Allergan, Inc.
Mr. Gregg served as the 2003-2004 Chair of the Research Foundation Board of the American Diabetes Association and serves on the boards of Vasogen, Inc., and LMS Medical Systems.
Mr. Gregg received a Bachelor of Science degree from Colorado State University in 1971. In 2003, Mr. Gregg and his wife were recognized by the American Diabetes Association with an award for Outstanding Service in Diabetes Research Funding.
Articles
Michele D. Huie
TCOYD Newsletter, Vol. 29, 2009
Terrance H. Gregg is TCOYD’s newest board member. Terry serves as CEO and President of DexCom, Inc., the company that first brought continuous glucose monitoring (CGM) to people with diabetes. Before DexCom, he was President and Chief Operating Officer of Medtronic Minimed for seven years. Terry and his wife Louise are big supporters of Taking Control of Your Diabetes. In this interview, we talk to Terry about his commitment to diabetes education, research, and the people living with this disease.
|
|
